Publications by authors named "Kelly Elleson"

Claim this Profile
T
The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy.
Michelle M Dugan, Kate E Beekman, Danielle K DePalo, Lily M Parker, Kelly M Elleson

Ann Surg Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional Cohort.
Kelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, Michelle M Dugan, Jonathan S Zager, Kelly M Elleson

Ann Surg Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the role of level 3 axillary lymph node dissection in metastatic melanoma: Can we predict involvement?
Lily M Parker, Kate E Beekman, Danielle K DePalo, Kelly M Elleson, Jonathan S Zager

J Surg Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Node-Positive Disease in Estrogen Receptor-Positive Breast Cancer Patients.
Julia Gallagher, Kelly M Elleson, Katherine Englander, Neha Chintapally, Weihong Sun

J Surg Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study.
Kate E Beekman, Danielle K DePalo, Lily M Parker, Kelly M Elleson, John E Mullinax

Cancer Control· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Predictive of Positive Lymph Nodes for Breast Cancer.
Kelly M Elleson, Katherine Englander, Julia Gallagher, Neha Chintapally, Weihong Sun

Curr Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Kristen E Rhodin, Sin-Ho Jung, Kelly Elleson, Danielle DePalo, Richard Straker

Ann Surg Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment with carboplatin and paclitaxel in melanoma progression after immune-related adverse events.
Özgecan Dülgar, Aditi Saha, Kelly M Elleson, Joseph Markowitz

Immunotherapy· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Characteristics Associated with Axillary Nodal Positivity in Triple Negative Breast Cancer.
Neha Chintapally, Katherine Englander, Julia Gallagher, Kelly Elleson, Weihong Sun

Diseases· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four cases of disseminated herpes simplex virus following talimogene laherparepvec injections for unresectable metastatic melanoma.
Kate E Beekman, Lily M Parker, Danielle K DePalo, Kelly M Elleson, Amod A Sarnaik

JAAD Case Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients.
Katherine Englander, Neha Chintapally, Julia Gallagher, Kelly Elleson, Weihong Sun

Curr Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genitourinary melanoma: An overview for the clinician.
Danielle K DePalo, Kelly M Elleson, Michael J Carr, Philippe E Spiess, Jonathan S Zager

Asian J Urol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current State of Cell Therapies for Breast Cancer.
Namrata Gautam, Kelly M Elleson, Ganesan Ramamoorthi, Brian J Czerniecki

Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on local and systemic therapies for nonmelanoma skin cancer.
Kelly M Elleson, Danielle K DePalo, Jonathan S Zager

Expert Rev Anticancer Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis